| Literature DB >> 30030612 |
Junfeng Zhang1,2, Qin Wang3,4, Cuiming Zhang5.
Abstract
OBJECTIVE: The study aimed to evaluate the role of lateral-wedge insoles in pain reduction and functional improvement among patients with medial knee osteoarthritis.Entities:
Keywords: Lateral-wedge insoles; Medial knee osteoarthritis; Meta-analysis
Mesh:
Year: 2018 PMID: 30030612 PMCID: PMC6132949 DOI: 10.1007/s00402-018-3004-z
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 3.067
Fig. 1Flow diagram for the study selection
Characteristics of included studies
| References | Country | Female, | Age | Body mass index | Intervention | Treatment dosage | Treatment duration | Outcome assessment |
|---|---|---|---|---|---|---|---|---|
| Baker et al. [ | USA | Wedge to neutral: 24(53) | Neutral to wedge: 67.8 (9.9) | Wedge to neutral: 33.0(4.8) | T: 5° | Worn for 7–8 h/d | 6 weeks | WOMAC |
| Bennell et al. [ | Australia | Treatment: 62 (60) | Treatment: 63.6 (8.1) | Treatment: 28.1 | Treatment group: LWI | Wear the insoles full time in their shoes | 12 months | WOMAC |
| Erhart-Hledik et al. [ | USA | Treatment: 14 (41) | Treatment: 61.4(9.2) | Treatment: 27.6 | Treatment group: bilateral neutrally | Worn for 6.4–7.9 h/d | 12 months | WOMAC |
| Pham et al. [ | France | Treatment: 54 (66) | Treatment: 64.0 | Treatment: 29.0 | Treatment group: LWI | checked | 24 months | WOMAC |
| Sattari et al. [ | Iran | Treatment total: 20 | Overall: 48 | NA | Treatment group: LWI (approximately 6°) | Whenever patients wore shoes | 9 months | Pain on walking (VAS) |
| Toda et al. [ | Japan | Treatment: 38 (88) | Treatment: 66.1 | Treatment: 24.7 | Treatment group: LWI | 5–10 h/day whenever wearing shoes | 12 weeks | Lequesne Index |
| Hsieh et al. [ | China (Taiwan) | Treatment: 38 (88) | Overall: 61.0 (9.9) | Overall: 25.0 (4.7) | Treatment group: LWI | NA | 6 months | The pain subscale score of the WOMAC; physical function subscale of the WOMAC assessment |
| Campos et al. [ | Brazil | Treatment: 18 (62.1) | Treatment: 65.2 (9.6) | Treatment: 30.8 (6.1) | a lateral-wedge insole with subtalar strapping (Group W), or a neutral insole with subtalar strapping (Group N–control) | worn for 5–10 h/day | 24 weeks | VAS, the WOMAC and Lequesne questionnaires |
| Barrios et al. [ | USA | Treatment: 19 (54.3); Control: 18 (60) | Treatment: 62.0 (7.4); Control: 62.8 (9.6) | Treatment: 34.2 (7.2) | Treatment: LWI; Control: neutral wedge | NA | 12 months | WOMAC |
| Maillefert et al. [ | France | Treatment: 54 (65.9) | Treatment: 64 (10.8); Control: 65.6 (9.9) | Treatment: 29 (5.6); Control: 28.5 (5.3) | Treatment: LWI; Control: neutral wedge | NA | 6 months | WOMAC |
WOMAC Western Ontario and McMaster Universities Arthritis Index, VAS visual analog scale, LWI lateral-wedge insole, N/A not applicable, T treatment group (lateral-wedge insole), C control group (neutral insole), W group W (a lateral-wedge insole with subtalar strapping), N group N (a neutral insole with subtalar strapping)
Fig. 2Forest Plot of heel wedge interventions on pain improvement. a Forest plot of heel wedge interventions on pain improvement among patients in Asia. b Forest plot of heel wedge interventions on pain improvement among patients in USA. c Forest plot of heel wedge interventions on pain improvement among patients in other areas. d Forest plot of heel wedge interventions on pain improvement
Fig. 3Funnel plots for heel wedge interventions on pain improvement
Fig. 4Forest plot of heel wedge interventions on function improvement
Fig. 5Funnel plots for heel wedge interventions on function improvement